Radiolabeled Somatostatin Analogues Therapy in Advanced Neuroendocrine Tumors: A Single Centre Experience

Table 6

Results of treatment responses tabulated on the basis of the type of treatment.

Type of treatment	CR	PR	SD	PD
^90Y-PRRT (33/59)	1/33 (3%)	13/33 (40%)	11/33 (33%)	8/33 (24%)
^177Lu-PRRT (10/59)	—	2/10 (20%)	6/10 (60%)	2/10 (20%)
Both ^90Y-PRRT and ^177Lu-PRRT (16/59)	—	9/16 (56%)	7/16 (44%)	—